PT80635B - PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT - Google Patents

PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT

Info

Publication number
PT80635B
PT80635B PT80635A PT8063585A PT80635B PT 80635 B PT80635 B PT 80635B PT 80635 A PT80635 A PT 80635A PT 8063585 A PT8063585 A PT 8063585A PT 80635 B PT80635 B PT 80635B
Authority
PT
Portugal
Prior art keywords
preparation
galenic form
delayed effect
new galenic
new
Prior art date
Application number
PT80635A
Other languages
Portuguese (pt)
Other versions
PT80635A (en
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT80635A publication Critical patent/PT80635A/en
Publication of PT80635B publication Critical patent/PT80635B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT80635A 1984-06-14 1985-06-12 PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT PT80635B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (2)

Publication Number Publication Date
PT80635A PT80635A (en) 1985-07-01
PT80635B true PT80635B (en) 1987-10-20

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80635A PT80635B (en) 1984-06-14 1985-06-12 PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490A0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
EP1189599A2 (en) * 1999-06-11 2002-03-27 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
JP3462490B2 (en) * 1999-08-04 2003-11-05 山之内製薬株式会社 Stable oral pharmaceutical composition
IL143375A0 (en) 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
CA2434835A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
WO2008070118A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
MX2011001864A (en) * 2008-08-20 2011-06-20 Univ Texas Hot-melt extrusion of modified release multi-particulates.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
FI64938C (en) * 1977-06-20 1984-02-10 Sandoz Ag PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DK154607C (en) * 1978-12-21 1989-06-05 Sandoz Ag PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION

Also Published As

Publication number Publication date
GB8727056D0 (en) 1987-12-23
SE8502950D0 (en) 1985-06-13
HU198844B (en) 1989-12-28
GB8514855D0 (en) 1985-07-17
FR2565822B1 (en) 1989-02-17
GB2196852A (en) 1988-05-11
BE902626A (en) 1985-12-10
NL194389B (en) 2001-11-01
NL194389C (en) 2002-03-04
PT80635A (en) 1985-07-01
ATA174885A (en) 1990-06-15
SE504583C2 (en) 1997-03-10
CA1264441A (en) 1990-01-16
LU85946A1 (en) 1986-01-24
GB2160100A (en) 1985-12-18
DE3520184C2 (en) 1997-03-13
GB2196852B (en) 1989-05-17
DK167649B1 (en) 1993-12-06
DK264785D0 (en) 1985-06-12
ES8702141A1 (en) 1987-01-01
HK25192A (en) 1992-04-10
DE3520184A1 (en) 1985-12-19
GB8727055D0 (en) 1987-12-23
DK264785A (en) 1985-12-15
IE851460L (en) 1985-12-14
AU4348685A (en) 1985-12-19
SE8502950L (en) 1985-12-15
GR851430B (en) 1985-11-25
GB2196851B (en) 1989-06-07
NZ212390A (en) 1992-02-25
CY1635A (en) 1992-11-06
IL75490A0 (en) 1985-10-31
IT8548210A0 (en) 1985-06-13
AT391806B (en) 1990-12-10
GB2196851A (en) 1988-05-11
GB2160100B (en) 1989-06-01
FR2565822A1 (en) 1985-12-20
IT1200080B (en) 1989-01-05
AU587190B2 (en) 1989-08-10
IE58834B1 (en) 1993-11-17
ES544075A0 (en) 1987-01-01
HUT40918A (en) 1987-03-30
NL8501578A (en) 1986-01-02
AU4454389A (en) 1990-03-22

Similar Documents

Publication Publication Date Title
PT80635B (en) PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM WITH A DELAYED EFFECT
PT80916B (en) PROCESS FOR THE PREPARATION OF A NEW MODIFICATION OF CRYSTALS
PT80573B (en) PROCESS FOR THE PREPARATION OF RECOMBINANT LINFOTOXIN
IT8403463A0 (en) PROCESS FOR THE PREPARATION OF PYRIDO-IMIDAZO-RIFAMICINS
BR8501583A (en) PROCESS FOR THE PREPARATION OF COMPOUNDS
PT81463B (en) PROCESS FOR THE PREPARATION OF NEW DERIVATIVES 5-AMINO-4-HYDROXYVALERYL
BR8702527A (en) PROCESS FOR THE PREPARATION OF A TRIAZOL-SULPHONAMIDE
BR8604182A (en) PROCESS FOR THE PRODUCTION OF ETERES
BR8500422A (en) PROCESS FOR THE PREPARATION OF POLYISOCIANATES WITH BIURET STRUCTURE
BR8406105A (en) PROCESS FOR THE PRODUCTION OF A NITRODIARYLAMINES
PT81714B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOUNDS OF THEOPHILINE WITH DELAYED EFFECT
PT81356B (en) PROCESS FOR THE PREPARATION OF AN ANTI-VEGETATIVE INK
PT81393B (en) PROCESS FOR THE PREPARATION OF OXINDOLIC ANTI-INFLAMMATORY AGENTS
PT83802B (en) PROCESS FOR THE MANUFACTURE OF A CONDIMENT
BR8501588A (en) PROCESS FOR THE PREPARATION OF POLYISOCIANATES
BR8502305A (en) PROCESS FOR THE PREPARATION OF ORGANOPOL ISSILOXANAS ORGANOFUNCIONAL
BR8505989A (en) PROCESS FOR THE PREPARATION OF AMINO-4-DIPHENYLAMINS
BR8501134A (en) PROCESS FOR THE PREPARATION OF GLYCIDITERES
PT81061B (en) PROCESS FOR THE PREPARATION OF A VACINAL POLIPEPTIDEO
IT1199413B (en) PROCESS FOR THE PREPARATION OF PIRIDO-IMIDAZO-RIFAMICINE
PT81487B (en) PROCESS FOR THE PREPARATION OF NEW TIENOPYRIDINE DERIVATIVES
PT80634B (en) PROCESS FOR THE PREPARATION OF NAFTOXACINS
PT80517B (en) Process for the preparation of a composition containing CHA extract
BR8504162A (en) PROCESS FOR THE PREPARATION OF CHLORINE-O-NITROANILINS
BR8501033A (en) PROCESS FOR THE PRODUCTION OF TIURAM POLYSULPHETS

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 971017 NOVARTIS AG CH